1 / 30

Cardiac Biomarkers: Key Takeaways for Use in Heart Failure and Acute Coronary Syndrome

Cardiac Biomarkers: Key Takeaways for Use in Heart Failure and Acute Coronary Syndrome. Cost of Heart Failure to Society. Challenges/Opportunities for Utilizing Biomarkers in the Management of Heart Failure. BNP and NT-proBNP for Diagnosis or Exclusion of Heart Failure.

nickan
Download Presentation

Cardiac Biomarkers: Key Takeaways for Use in Heart Failure and Acute Coronary Syndrome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cardiac Biomarkers: Key Takeaways for Use in Heart Failure and Acute Coronary Syndrome

  2. Cost of Heart Failure to Society

  3. Challenges/Opportunities for Utilizing Biomarkers in the Management of Heart Failure

  4. BNP and NT-proBNP for Diagnosis or Exclusion of Heart Failure

  5. Correlations of Natriuretic Peptides With Cardiac Structure and Function

  6. The Differential Diagnosis of an Elevated BNP or NT-proBNP

  7. BNP and NT-proBNP for Prognosis in Heart Failure

  8. BNP/NT-proBNP and Stage C HF Prognosis

  9. The Importance of Serial NP Measurements for Prognostication in Chronic HF

  10. IMPROVE HR: Improvements in Quality Measures at 24 Months (Patient Level Analysis)

  11. Therapies With Effects on B-Type Natriuretic Peptide Levels

  12. Biomarker-Guided Heart Failure Trials

  13. Understanding Heterogeneous Results in “Guided Therapy” Trials

  14. TIME CHF: Cost Effectiveness

  15. Emerging Uses of Natriuretic Peptides to Guide Therapy

  16. Emerging Biomarkers in Heart Failure

  17. Biomarkers for Detection of Myocardial Infarction

  18. Diagnostic Performance of Sensitive Assays for Troponin

  19. Elevations of Cardiac Troponin Values Because of Myocardial Injury

  20. Elevations of Cardiac Troponin Values Because of Myocardial Injury

  21. Universal Classification of Myocardial Infarction

  22. Universal Classification of Myocardial Infarction (cont)

  23. Prognostic Use of a Sensitive Current Generation Assay for cTn

  24. cTnl Assay Problems

  25. Elevations of Troponins Without Overt Ischemic Heart Disease

  26. Abbreviations

  27. Abbreviations

  28. Abbreviations

More Related